Rigaku Americas Corporation recently acquired the handheld Raman technology and product lines from BaySpec, Inc. and concurrently formed a new division, Rigaku Raman Technologies Inc., for research and development, engineering, production, marketing, and distribution.
Rigaku Americas Corporation recently acquired the handheld Raman technology and product lines from BaySpec, Inc. and concurrently formed a new division, Rigaku Raman Technologies Inc., for research and development, engineering, production, marketing, and distribution.
The company’s new handheld Raman instruments combine optics and spectral analysis techniques with optical components developed for the telecommunications industry, resulting in handheld chemical identification and composition analyzers for explosives detection, including improvised explosive device detection; narcotics and other controlled substances detection and identification; counterfeit drug detection; and detection and identification of many other sample types; for homeland security; pharmaceutical, cosmetics, food, wine, beer, and agricultural feed quality assurance and quality control; medical diagnostics; petrochemical exploration and process control; forensics; archeometry; and other applications.
The new company will be co-located in San Jose, California, and The Woodlands, Texas, and will be led by analytical technology entrepreneur Hal Grodzins, as president and CEO.
An Interview with AES Mid-Career Award Recipient Jason Dwyer
July 25th 2024Jason Dwyer of the University of Rhode Island has been named the recipient of the American Electrophoresis Society’s Mid-Career Award, which honors exceptional contributions to the field of electrophoresis, microfluidics, and related areas by an individual who is currently in the middle of their career.
Glucose's Impact on Brain Cancer Cells Unveiled Through Raman Imaging
July 25th 2024Researchers have used Raman spectroscopy and chemometric methods to reveal how glucose affects normal and cancerous brain cell metabolism. Their findings highlight specific biomarkers that can distinguish metabolic changes, potentially aiding in cancer research and treatment.